SANA Sana Biotechnology, Inc.

Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are more than 250 people working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, Cambridge, and South San Francisco.

$4.29  -0.11 (-2.50%)
As of 05/24/2022 12:00:26 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/12/2006
Outstanding shares:  189,667,928
Average volume:  1,642,082
Market cap:   $849,712,317
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMFJJ97
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.15
PS ratio:   0.00
Return on equity:   -29.47%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy